Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,92119,940 of 20,252 grants

Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies.
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

Summary - A fundamental theme in personalized cancer medicine is to identify specific subgroups of patients, based on molecular biomarkers and/or tumor signatures, which will subse...

$507.4K
USD
Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

SUMMARY The dysregulation of mitochondrial networks responsible for maintaining normal metabolism is an established hallmark of cancer and an early event in tumorigenesis. The disr...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
MnSOD-K68-Ac reprograms a lineage plasticity switch / stemness in ER+ breast malignancies
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2025

SUMMARY The dysregulation of mitochondrial networks responsible for maintaining normal metabolism is an established hallmark of cancer and an early event in tumorigenesis. The disr...

$1.45M
USD
Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.45M
USD
Completed OTHER RESEARCH-RELATED
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT This project takes a unique dynamic view of signaling by receptor tyrosine kinases (RTKs), testing the hypothesis that signaling specificity is kinetically...

$977.6K
USD
Completed NON-SBIR/STTR RPGS
Novel dual-targeted inhibitors of EGFR and aurora kinase for lung cancer
NATIONAL CANCER INSTITUTE Ferris State University United States 2021 – 2023

PROJECT SUMMARY Small molecule EGFR inhibitors constitute the recommended therapy for EGFR-positive non-small cell lung cancer (NSCLC).Resistance was first reported to EGFR inhibit...

$3.78M
USD
Completed OTHER RESEARCH-RELATED
Supporting Personalized Decision Making for Breast Cancer Screening among Older Women
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT In the United States, approximately half of women 75 and older undergo screening mammography.Despite widespread use, the benefits of mammography in this ag...

$2.57M
USD
Completed OTHER RESEARCH-RELATED
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT This project takes a unique dynamic view of signaling by receptor tyrosine kinases (RTKs), testing the hypothesis that signaling specificity is kinetically...

$959.9K
USD
Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.32M
USD
Completed OTHER RESEARCH-RELATED
Supporting Personalized Decision Making for Breast Cancer Screening among Older Women
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT In the United States, approximately half of women 75 and older undergo screening mammography. Despite widespread use, the benefits of mammography in this a...

$2.57M
USD
Completed OTHER RESEARCH-RELATED
Supporting Personalized Decision Making for Breast Cancer Screening among Older Women
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT In the United States, approximately half of women 75 and older undergo screening mammography. Despite widespread use, the benefits of mammography in this a...

$2.56M
USD
Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.35M
USD
Completed OTHER RESEARCH-RELATED
Supporting Personalized Decision Making for Breast Cancer Screening among Older Women
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT In the United States, approximately half of women 75 and older undergo screening mammography. Despite widespread use, the benefits of mammography in this a...

$2.56M
USD
Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.15M
USD
Completed NON-SBIR/STTR RPGS
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

PROJECT SUMMARY Recent advances using CAR T cells in lymphoid malignancies have made it clear that manipulation of the host immune system can radically alter the course of a cancer...

$7.2M
USD
Completed NON-SBIR/STTR RPGS
Investigating multifactorial beta-catenin activation in hepatocellular cancers
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2025

Abstract Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options, and lacks molecular- targeted therapies. Activation of Wnt/?-catenin cascade has been...

$5.12M
USD
Completed TRAINING, INDIVIDUAL
Chromatin Organization in Glioma Initiation
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2024

Project Summary Glioma is the most common primary brain tumor and represents a disproportionate percentage of cancer fatalities in relation to its incidence.In the last decade, it...

$378.1K
USD
Completed NON-SBIR/STTR RPGS
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

PROJECT SUMMARY Recent advances using CAR T cells in lymphoid malignancies have made it clear that manipulation of the host immune system can radically alter the course of a cancer...

$6.89M
USD
Completed NON-SBIR/STTR RPGS
Investigating multifactorial beta-catenin activation in hepatocellular cancers
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2022

Abstract Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options, and lacks molecular- targeted therapies. Activation of Wnt/β-catenin cascade has been...

$1.67M
USD
Completed TRAINING, INDIVIDUAL
Chromatin Organization in Glioma Initiation
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2024

Project SummaryGlioma is the most common primary brain tumor and represents a disproportionate percentage of cancer fatalities in relationto its incidence. In the last decade, it h...

$517.5K
USD